Courtney Breen

Stock Analyst at Bernstein

(4.79)
# 547
Out of 5,134 analysts
321
Total ratings
94.8%
Success rate
27%
Average return

Stocks Rated by Courtney Breen

Eli Lilly and Company
Nov 16, 2026
Maintained: Buy
Price Target: $1,450
Current: $1,443.50
Upside: +0.45%
Amgen
Nov 4, 2026
Rated: Hold
Price Target: $345 → $400
Current: $465.67
Upside: -14.10%
Bristol-Myers Squibb Company
Nov 2, 2026
Reiterated: Hold
Price Target: $61
Current: $63.43
Upside: -3.83%
AbbVie
Oct 25, 2026
Reiterated: Hold
Price Target: $225 → $230
Current: $295.03
Upside: -22.04%
Gilead Sciences
Oct 25, 2026
Reiterated: Buy
Price Target: $160
Current: $168.08
Upside: -4.81%
Merck & Co.
Oct 25, 2026
Reiterated: Hold
Price Target: $105
Current: $147.76
Upside: -28.94%
Moderna
Oct 25, 2026
Reiterated: Hold
Price Target: $45
Current: $223.37
Upside: -79.85%
Pfizer
Oct 25, 2026
Reiterated: Hold
Price Target: $29
Current: $28.89
Upside: +0.38%